High-dose radiotherapy or concurrent chemo-radiation in lung cancer patients only induces a temporary, reversible decline in QoL

Radiotherapy and Oncology

Volumn 91, Issue 3, 2009, Pages 443-448

  Pijls Johannesma, Madelon ^a,b   Houben, Ruud ^a   Boersma, Liesbeth ^a,b   Grutters, Janneke ^a   Seghers, Katarina ^c   Lambin, Philippe ^a,b   Wanders, Rinus ^a,b   Ruysscher, Dirk De ^a,b  

^a MAASTRO CLINIC   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c HASSELT UNIVERSITY   (Belgium)

Author keywords

Concurrent chemo radiation; Esophageal toxicity; High dose radiotherapy; Lung cancer; QoL

Indexed keywords

CARBOPLATIN; ETOPOSIDE; GEMCITABINE;

ADULT; AGED; ANOREXIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; COGNITION; CONSTIPATION; CONTROLLED STUDY; COUGHING; DIARRHEA; DISEASE SEVERITY; DYSPHAGIA; DYSPNEA; EMOTION; ESOPHAGITIS; ESOPHAGUS DISEASE; FATIGUE; FEMALE; FUNCTIONAL ASSESSMENT; HEMOPTYSIS; HOARSENESS; HUMAN; INSOMNIA; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; LUNG TOXICITY; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; NAUSEA; PAIN; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; RADIATION DOSE; RADIATION INJURY; SOCIAL INTERACTION; THORAX PAIN; VOMITING;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CARCINOMA, NON-SMALL-CELL LUNG; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LINEAR MODELS; LONGITUDINAL STUDIES; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY OF LIFE; RADIATION INJURIES; SMALL CELL LUNG CARCINOMA; TREATMENT OUTCOME;

EID: 65649122699     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2009.02.010     Document Type: Article

References (29)

1. Shibuya K., Mathers C.D., Boschi-Pinto C., Lopez A.D., and Murray C.J. Global and regional estimates of cancer mortality and incidence by site: II. Results for the global burden of disease 2000. BMC Cancer 2 (2002) 37
2. Ferlay J., Autier P., Boniol M., Heanue M., Colombet M., and Boyle P. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 18 (2007) 581-592
3. Auperin A., Rolland E., and Curran W.J. Concomitant radio-chemotherapy (RT-CT) versus sequential RT-CT in locally advanced non-small cell lung cancer (NSCLC): a meta-analysis using individual patient data (IPD) from randomised clinical trials (RCTs). J Thorac Oncol 2 (2007) S310 [Abstr. A311-A305]
4. Turrisi III A.T., Kim K., Blum R., et al. Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide. N Engl J Med 340 (1999) 265-271
5. Zatloukal P., Petruzelka L., Zemanova M., et al. Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized study. Lung Cancer 46 (2004) 87-98
6. Fournel P., Robinet G., Thomas P., et al. Randomized phase III trial of sequential chemoradiotherapy compared with concurrent chemoradiotherapy in locally advanced non-small-cell lung cancer: Groupe Lyon-Saint-Etienne d'Oncologie Thoracique-Groupe Francais de Pneumo-Cancerologie NPC 95-01 Study. J Clin Oncol 23 (2005) 5910-5917
7. Furuse K., Fukuoka M., Kawahara M., et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer. J Clin Oncol 17 (1999) 2692-2699
8. Vokes E.E., Crawford J., Bogart J., Socinski M.A., Clamon G., and Green M.R. Concurrent chemoradiotherapy for unresectable stage III non-small cell lung cancer. Clin Cancer Res 11 (2005) 5045s-5050s
9. Auchter R.M., Scholtens D., Adak S., Wagner H., Cella D.F., and Mehta M.P. Quality of life assessment in advanced non-small-cell lung cancer patients undergoing an accelerated radiotherapy regimen: report of ECOG study 4593. Eastern Cooperative Oncology Group. Int J Radiat Oncol Biol Phys 50 (2001) 1199-1206
10. Rubin P., Constine III L.S., Fajardo L.F., Phillips T.L., and Wasserman T.H. EORTC Late Effects Working Group. Overview of late effects normal tissues (LENT) scoring system. Radiother Oncol 35 (1995) 9-10
11. Rubin P., Constine L.S., Fajardo L.F., Phillips T.L., and Wasserman T.H. RTOG Late Effects Working Group. Overview. Late effects of normal tissues (LENT) scoring system. Int J Radiat Oncol Biol Phys 31 (1995) 1041-1042
12. McLachlan S.-.A., Devins G.M., and Godwin P.J. Validation of the European Organisation for Research and Treatment of Cancer quality of life questionaire (QLQ-C30) as a measure of psychosocial function in breast cancer patients. Eur J Cancer 34 (1998) 510-517
13. Bergman B., Aaronson N.K., Ahmedzai S., Kaasa S., and Sullivan M. The EORTC QLQ-LC13: a modular supplement to the EORTC Core Quality of Life Questionnaire (QLQ-C30) for use in lung cancer clinical trials. EORTC Study Group on Quality of Life. Eur J Cancer 30A (1994) 635-642
14. ICRU. International Commission on radiation Units and Measurements report 50. Prescribing, recording and reporting photon beam therapy. Oxford: Oxford University Press; 1993.
15. Bradley J., Graham M.V., Winter K., et al. Toxicity and outcome results of RTOG 9311: a phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma. Int J Radiat Oncol Biol Phys 61 (2005) 318-328
16. De Ruysscher D., Wanders R., van Haren E., et al. HI-CHART: a phase I/II study on the feasibility of high-dose continuous hyperfractionated accelerated radiotherapy in patients with inoperable non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 71 (2008) 132-138
17. De Ruysscher D., Bremer R.H., Koppe F., et al. Omission of elective node irradiation on basis of CT-scans in patients with limited disease small cell lung cancer: a phase II trial. Radiother Oncol 80 (2006) 307-312
18. Dagnelie P.C., Pijls-Johannesma M.C., Lambin P., Beijer S., De Ruysscher D., and Kempen G.I. Impact of fatigue on overall quality of life in lung and breast cancer patients selected for high-dose radiotherapy. Ann Oncol 18 (2007) 940-944
19. Langendijk J.A., Aaronson N.K., de Jong J.M., et al. Prospective study on quality of life before and after radical radiotherapy in non-small-cell lung cancer. J Clin Oncol 19 (2001) 2123-2133
20. Langendijk J.A., Aaronson N.K., de Jong J.M., et al. Quality of life after curative radiotherapy in stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 53 (2002) 847-853
21. Langendijk J.A., Aaronson N.K., ten Velde G.P., de Jong J.M., Muller M.J., and Wouters E.F. Pretreatment quality of life of inoperable non-small cell lung cancer patients referred for primary radiotherapy. Acta Oncol 39 (2000) 949-958
22. Siddiqui F., Kohl R., Swann S., Watkins-Bruner D., and Movsas B. Gender differences in pretreatment quality of life in a prospective lung cancer trial. J Support Oncol 6 (2008) 33-39
23. Jacot W., Colinet B., Bertrand D., et al. Quality of life and comorbidity score as prognostic determinants in non-small-cell lung cancer patients. Ann Oncol 19 (2008) 1458-1464
24. Movsas B., Scott C., and Watkins-Bruner D. Pretreatment factors significantly influence quality of life in cancer patients: a Radiation Therapy Oncology Group (RTOG) analysis. Int J Radiat Oncol Biol Phys 65 (2006) 830-835
25. Manser R.L., Wright G., Byrnes G., et al. Validity of the assessment of quality of life (AQoL) utility instrument in patients with operable and inoperable lung cancer. Lung Cancer 53 (2006) 217-229
26. Lange P., Parner J., Vestbo J., Schnohr P., and Jensen G. A 15-year follow-up study of ventilatory function in adults with asthma. N Engl J Med 339 (1998) 1194-1200
27. Scharloo M., Kaptein A.A., Weinman J.A., Willems L.N., and Rooijmans H.G. Physical and psychological correlates of functioning in patients with chronic obstructive pulmonary disease. J Asthma 37 (2000) 17-29
28. Schild S.E., and Bogart J.A. Innovations in the radiotherapy of non-small cell lung cancer. J Thorac Oncol 1 (2006) 85-92
29. Pijls-Johannesma M., Grutters J.P., Lambin P., and De Ruysscher D. Particle therapy in lung cancer: where do we stand?. Cancer Treat Rev 34 (2008) 259-267